Jaguar Health
JAGX
Jaguar Health (JAGX) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 30, 2026
- EPS actual
- −$235.50
- EPS estimate
- −$782.25
- EPS surprise
- +69.89%
- Revenue surprise
- −71.11%
- Revenue
- $1.2M
- Revenue estimate
- $4.2M
- Reported
- Aug 19, 2026
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Aug 19, 2026 | −$782.25 | −$235.50 | +69.89% | $1.2M | SEC |
| Q3 2025 | Nov 14, 2025 | −$2,667.00 | −$3,297.00 | −23.62% | $3.1M | SEC |
| Q2 2025 | Aug 14, 2025 | −$3,743.25 | −$5,386.50 | −43.90% | $3.0M | SEC |
| Q1 2025 | May 15, 2025 | −$5,680.50 | −$8,767.50 | −54.34% | $2.2M | SEC |
| Q4 2024 | Mar 31, 2025 | −$9,712.50 | −$7,728.00 | +20.43% | $3.5M | SEC |
| Q3 2024 | Nov 13, 2024 | −$31,106.25 | −$13,781.25 | +55.70% | $3.1M | SEC |
| Q2 2024 | Aug 13, 2024 | −$15,805.12 | −$53,025.00 | −235.49% | $2.7M | SEC |
| Q1 2024 | May 14, 2024 | −$23,625.00 | −$47,250.00 | −100.00% | $2.4M | SEC |
| Q4 2023 | Apr 1, 2024 | −$771,749.93 | $1,102,499.90 | +242.86% | $2.3M | SEC |
| Q3 2023 | Nov 14, 2023 | −$968,624.91 | −$299,249.97 | +69.11% | $2.8M | SEC |
| Q2 2023 | Aug 14, 2023 | −$1,204,874.89 | −$330,749.97 | +72.55% | $2.7M | SEC |
| Q1 2023 | May 15, 2023 | −$3,543,749.67 | −$1,882,124.83 | +46.89% | $2.0M | SEC |
| Q3 2022 | Nov 14, 2022 | −$4,429,687.09 | −$7,087,499.34 | −60.00% | $3.1M | — |
| Q2 2022 | Aug 22, 2022 | −$12,993,748.80 | −$7,087,499.34 | +45.45% | $2.9M | — |
| Q1 2022 | May 10, 2022 | −$10,335,936.54 | −$23,624,997.81 | −128.57% | $2.6M | — |
| Q4 2021 | Mar 11, 2022 | −$5,315,624.51 | −$18,309,373.31 | −244.44% | $2.1M | — |
| Q3 2021 | Nov 17, 2021 | −$13,879,686.22 | −$15,946,873.53 | −14.89% | $630,000.00 | — |
| Q2 2021 | Aug 13, 2021 | −$7,087,499.34 | −$17,718,748.36 | −150.00% | $385,000.00 | — |
| Q1 2021 | May 17, 2021 | −$3,543,749.67 | −$17,718,748.36 | −400.00% | $1.2M | — |
| Q3 2020 | Nov 16, 2020 | −$19,490,623.20 | −$37,209,371.56 | −90.91% | $2.8M | — |
Quarterly revenue
Frequently asked questions
When did Jaguar Health (JAGX) last report earnings?
Jaguar Health last reported on Aug 19, 2026, covering fiscal Q2 2026.
Did JAGX beat earnings estimates?
Yes. Jaguar Health reported EPS of −$235.50 for Q2 2026 against a −$782.25 estimate — a 69.89% beat.
How much revenue did JAGX report last quarter?
Jaguar Health reported $1.2M in revenue for Q2 2026, against a consensus estimate of $4.2M.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.